Condition
Brain Natriuretic Peptide
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Completed3
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06667128Not ApplicableNot Yet Recruiting
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
NCT00368147Completed
Access Creation for Hemodialysis: Association With Structural Changes of the Heart
NCT03366857Phase 4Completed
Effect of Supplemental Oxygen on Perioperative BNP Concentration in Cardiac Risk Patients
NCT04238806Not ApplicableCompletedPrimary
Desflurane,Brain Natriuretic Peptide and Cardiac Surgery
Showing all 4 trials